You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETON Exercise Disclosure
Brynjelsen Sean · SEC Form 4 · Filed Jul 14, 2026
Exercise
Reported value range
Not reported
Brynjelsen Sean President & CEO
ETON
Eton Pharmaceutcials
ETON
Transaction date
Jul 12, 2026
Public filing date
Jul 14, 2026
Filing lag
Filed 2 days later
ETON daily price context
Close on/before transaction
$36.61
Jul 10, 2026
First close after public filing
$38.5
Jul 15, 2026
30-day return after filing
+5.97%
Through Aug 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 27,500 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-023570
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$274K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Exercise | Jul 14, 2026 | $274K |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Jul 14, 2026 | $0 |
| Eton Pharmaceuticals, Inc. ETON Current | Exercise | Jul 12, 2026 | Not reported |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Jul 12, 2026 | $0 |